Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €67.70 EUR
Change Today -0.63 / -0.92%
Volume 0.0
0MJA On Other Exchanges
Symbol
Exchange
New York
As of 1:22 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (0MJA) Snapshot

Open
€68.25
Previous Close
€68.33
Day High
€68.25
Day Low
€66.74
52 Week High
04/10/15 - €97.08
52 Week Low
08/24/15 - €64.85
Market Cap
13.7B
Average Volume 10 Days
0.6
EPS TTM
--
Shares Outstanding
202.7M
EX-Date
06/18/15
P/E TM
--
Dividend
€1.63
Dividend Yield
1.99%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (0MJA)

mead johnson nutrition co (0MJA) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names. The company also provides specialty formula products, including formulas for addressing various conditions or special medical needs, such as cow’s milk protein and multiple other food allergies, premature and low birth weight infants, and premature babies at home, as well as produces medical foods for nutritional management of individuals under the Nutramigen, Puramino, Enfamil Premature, and EnfaCare. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

7,700 Employees
Last Reported Date: 02/27/15
Founded in 1905

mead johnson nutrition co (0MJA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $551.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $407.5K
Compensation as of Fiscal Year 2014.

mead johnson nutrition co (0MJA) Key Developments

Mead Johnson Nutrition Company Announces Management Changes

Mead Johnson Nutrition Company, as of September 1, 2015, the company appointed Mr. Michel Martinus Gerardus Cup as the company's executive vice president and chief financial officer. Simultaneous with this appointment, the company has appointed Mr. Cup as the company's controller and treasurer. In his capacity as Controller, Mr. Cup shall be the company's chief accounting officer. As a result, Mr. Charles M. Urbain will no longer serve as the Company's Interim Controller and Treasurer as of September 1, 2015. Michel Cup, age 45, was most recently the Chief Financial Officer (CFO) of D.E Master Blenders 1753.

Mead Johnson Nutrition Company Announces Settlement with U.S. Securities and Exchange Commission

Mead Johnson Nutrition Company announced that it has entered into a settlement agreement with the U.S. Securities and Exchange Commission fully resolving the SEC’s investigation of certain of Mead Johnson’s promotional practices in China during the period 2008-2013. The investigation was first disclosed by Mead Johnson in 2013. Under the terms of the settlement agreement, Mead Johnson has agreed to disgorgement, as well as the payment of pre-judgment interest and a penalty, resulting in an aggregate payment of $12,030,000. This payment is in line with the expense provision the company took related to the SEC investigation within its first quarter, 2015. The settlement agreement provides that Mead Johnson neither admits nor denies the allegations in the settlement and order. Further, the agreement credits Mead Johnson for its cooperation with the investigation and for taking a number of positive steps to bolster its compliance program, function and processes.

Mead Johnson Nutrition Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Capital Spending Guidance for the Full Year of 2015

Mead Johnson Nutrition Company announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $1,032.4 million compared to $1,111.1 million a year ago. Earnings before interest and income taxes were $229.2 million compared to $244.9 million a year ago. Earnings before income taxes were $215.3 million compared to $229.6 million a year ago. Net earnings were $162.6 million compared to $176.1 million a year ago. Net earnings attributable to shareholders were $162.9 million or $0.80 per diluted share compared to $171.4 or $0.84 per diluted share million a year ago. For the six months, the company reported net sales of $2,126.8 million compared to $2,224.4 million a year ago. Earnings before interest and income taxes were $514.4 million compared to $536.1 million a year ago. Earnings before income taxes were $486.7 million compared to $508.4 million a year ago. Net earnings were $369.7 million compared to $383.9 million a year ago. Net earnings attributable to shareholders were $370.3 million or $1.82 per diluted share compared to $373.8 or $1.84 per diluted share million a year ago. Net cash provided by operating activities was $456.5 million compared to $304.0 million a year ago. Capital expenditures were $80.0 million compared to $94.8 million a year ago. Debt stood at $1.5 billion as of June 30, 2015, with its net debt position close to 0. For the full year of 2015, capital spending expectations remain unchanged at around $175 million. This is in line with its long-term goal of about 4% of sales. Depreciation and amortization expense is expected to be around $100 million for the full year. On a full year basis, the company expects the non-GAAP effective tax rate to be approximately 24%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
0MJA:GR €67.70 EUR -0.63

0MJA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 5,004 INR +292.10
Biostime International Holdings Ltd $12.30 HKD -0.02
Perrigo Co PLC $179.85 USD +0.39
Hain Celestial Group Inc/The $58.75 USD -0.20
Yakult Honsha Co Ltd ¥6,210 JPY -200.00
View Industry Companies
 

Industry Analysis

0MJA

Industry Average

Valuation 0MJA Industry Range
Price/Earnings 21.6x
Price/Sales 3.6x
Price/Book 20.4x
Price/Cash Flow 21.5x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.meadjohnson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.